Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)

• Status: Unknown status
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Our aim is to access whether we can achieve equivalent pregnancy rates by the addition of six doses of luteal support with recLH after agonist triggering for IVF cycles in the absence of OHSS.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universitair Ziekenhuis Brussel
• Collaborator: Merck Serono International SA
• Treatments: Deslorelin; Progesterone

Criteria

Inclusion Criteria:

• < 36years,

• single blastocystET,

• FSH < 12

Exclusion Criteria:

• endometriosis,

• 3 and 4,

• pco,

• frozen sperm